New FDA guidance on evaluating the safety of gene therapies will establish a more predictable development process as these measures are implemented

They provide a standardized, layered framework for uncovering off-target effects and other safety issues

https://www.biospace.com/drug-development/fda-bolsters-bespoke-therapy-framework-with-new-draft-safety-guidelines